A cannabis charity raised over €400,000 to make the trial possible.
A new report highlights the breakthroughs and barriers in the pharmaceutical cannabis space over the last 13 years.
Cannabis scientist Lex Pelger brings you the latest in cannabinoid research.
The UK saw the second highest number of clinical trials on cannabinoids in the last decade, the majority linked to GW Pharmaceuticals.
The trial on non-cancer related chronic pain will recruit up to 5,000 patients.
Pain is the most common indication to be studied in cannabinoid clinical trials since 2010, says an upcoming report.
Cannabis scientist Lex Pelger brings you the latest in cannabinoid research.
Researchers at the University of Edinburgh have received £1.55 million in grant funding for two Phase II clinical trials.
The trial has been carried out by Radicle Science and Open Book Extracts.
A new study has demonstrated the efficacy of a cannabinoid receptor agonist for the treatment of amyopathic dermatomyositis.
